These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 37511902)

  • 1. Cell Culture Systems for Studying Hepatitis B and Hepatitis D Virus Infections.
    Lee GS; Purdy MA; Choi Y
    Life (Basel); 2023 Jul; 13(7):. PubMed ID: 37511902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
    Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
    J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell Culture Models for the Study of Hepatitis D Virus Entry and Infection.
    Heuschkel MJ; Baumert TF; Verrier ER
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Host Responses to Hepatitis B and Delta Viral Infections in a Micro-scalable Hepatic Co-culture System.
    Winer BY; Gaska JM; Lipkowitz G; Bram Y; Parekh A; Parsons L; Leach R; Jindal R; Cho CH; Shrirao A; Novik E; Schwartz RE; Ploss A
    Hepatology; 2020 Jan; 71(1):14-30. PubMed ID: 31206195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell Culture Models for the Investigation of Hepatitis B and D Virus Infection.
    Verrier ER; Colpitts CC; Schuster C; Zeisel MB; Baumert TF
    Viruses; 2016 Sep; 8(9):. PubMed ID: 27657111
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Guo H; Urban S; Wang W
    Front Microbiol; 2023; 14():1169770. PubMed ID: 37089540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
    He W; Ren B; Mao F; Jing Z; Li Y; Liu Y; Peng B; Yan H; Qi Y; Sun Y; Guo JT; Sui J; Wang F; Li W
    PLoS Pathog; 2015 Apr; 11(4):e1004840. PubMed ID: 25902143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
    Qiao L; Sui J; Luo G
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
    Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of hepatitis B and delta virus infection.
    Dandri M; Lütgehetmann M
    J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus.
    Yan H; Li W
    Dig Dis; 2015; 33(3):388-96. PubMed ID: 26045274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducers of the NF-κB pathways impair hepatitis delta virus replication and strongly decrease progeny infectivity
    Michelet M; Alfaiate D; Chardès B; Pons C; Faure-Dupuy S; Engleitner T; Farhat R; Riedl T; Legrand AF; Rad R; Rivoire M; Zoulim F; Heikenwälder M; Salvetti A; Durantel D; Lucifora J
    JHEP Rep; 2022 Mar; 4(3):100415. PubMed ID: 35141510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of Na
    Zakrzewicz D; Geyer J
    Biol Chem; 2023 Jun; 404(7):673-690. PubMed ID: 37103224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategies to inhibit entry of HBV and HDV into hepatocytes.
    Urban S; Bartenschlager R; Kubitz R; Zoulim F
    Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment.
    Giersch K; Perez-Gonzalez P; Hendricks L; Goldmann N; Kolbe J; Hermanussen L; Bockmann JH; Volz T; Volmari A; Allweiss L; Petersen J; Glebe D; Lütgehetmann M; Dandri M
    JHEP Rep; 2023 Apr; 5(4):100673. PubMed ID: 36908749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell Culture Models for Hepatitis B and D Viruses Infection: Old Challenges, New Developments and Future Strategies.
    Carpentier A
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications.
    Li W; Urban S
    J Hepatol; 2016 Apr; 64(1 Suppl):S32-S40. PubMed ID: 27084034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of NTCP-inhibitor myrcludex B.
    Cheng D; Han B; Zhang W; Wu W
    J Viral Hepat; 2021 Jun; 28(6):852-858. PubMed ID: 33599010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a Monoclonal Antibody against Human NTCP That Blocks Hepatitis B Virus Infection.
    Takemori T; Sugimoto-Ishige A; Nishitsuji H; Futamura Y; Harada M; Kimura-Someya T; Matsumoto T; Honma T; Tanaka M; Yaguchi M; Isono K; Koseki H; Osada H; Miki D; Saito T; Tanaka T; Fukami T; Goto T; Shirouzu M; Shimotohno K; Chayama K
    J Virol; 2022 Mar; 96(5):e0168621. PubMed ID: 34985994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection.
    Palatini M; Müller SF; Kirstgen M; Leiting S; Lehmann F; Soppa L; Goldmann N; Müller C; Lowjaga KAAT; Alber J; Ciarimboli G; Ziebuhr J; Glebe D; Geyer J
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.